At present there are same studies illustrating the efficiency of aromatase inhibitors ın women with pain from rectovaginal endometriosis refractory to other medical or surgical treatment and treating postmenopausal endometriosis [19]. The gene discussed is CYP19A1; the disease is endometriosis.